Category: Kane
-
Nio (NIO.NYSE) surges 12%: Chinese Gov. doesn’t want Tesla (TSLA.Q) to humiliate the locals
NIO took a leaf out of Apple’s (AAPL.Q) playbook and outsourced production to a to a purpose-built factory run by JAC Motors (江淮汽车) a Chinese state-owned automobile manufacturer.
-
Stocks tank, gold surges – my locked-down communist wife tells a grim COVID19 virus story
“While the comparison to SARS may provide some guidance, important changes have been experienced in China and the Chinese gold market since the 2003 outbreak,” stated the WGC.
-
Vext Science (VEXT.C) ramps up Hemp/CBD operation in Kentucky
In VEXT’s latest financials we learned that “Gross Revenues increased 36% to USD $18.8 million for the nine months ended September 30, 2019 from USD $13.8 million for the nine months ended September 30, 2018.”
-
Sprint (S.NYSE), T-Mobile (TMUS.Q) gain $41 billion after gullible judge gives thumbs up to mega-merger
Judge Marrero said that opposing states “failed to persuade him that a merger of the No. 3 and 4 carriers would harm consumers”.
-
vTv Therapeutics (VTVT.Q) surges 55% on type 1 diabetes drug trial
“A once-a-day pill that reduces HbA1c and improves time in range with continuous glucose monitoring, without increasing hypoglycemia or any signal for adverse events, is a big win for the future care of type 1 diabetes,” stated clinical researcher Dr. John Buse.
-
World Class Extractions (PUMP.C) CEO Rosy Mondin lays out her 2020 plans
The merger of World-Class Extractions Inc. and Quadron Cannatech Corporation in 2019 was a significant milestone, as the combination of capital, experience, and technology has laid the foundation for our plans in 2020 and beyond.
-
Patriot One (PAT.T) lands a $975,000 government contract
The PATSCAN Multi-Sensor Covert Threat Detection Platform is a layered multi-sensor platform – integrated with A.I Managed security system to detect and combat active threats before they occur.
-
Resverlogix (RVX.T), Sirona Biochem (SBM.V), Sernova (SVA.V): 3 Canadian biotechs tackle a $330 billion health crisis
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP.